Novel immunotherapy for peritoneal dissemination of murine colon cancer with macrophage inflammatory protein-1β mediated by a tumor-specific vector, HVJ cationic liposomes

Cancer Gene Therapy

Volumn 8, Issue 11, 2001, Pages 852-860

  Miyata, Toshio ^a   Yamamoto, Seiji ^a,b   Sakamoto, Kayo ^a   Morishita, Ryuichi ^a   Kaneda, Yasufumi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

CD4+ T cell; Chemokine; HVJ cationic liposome; MIP 1 ; Murine colon cancer; Peritoneal dissemination

Indexed keywords

LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN 1BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNOTHERAPY; CANCER SURVIVAL; COLON CANCER; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; IMMUNE RESPONSE; MALE; MOUSE; NONHUMAN; PARAINFLUENZA VIRUS 1; PERITONEUM METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; COLONIC NEOPLASMS; GENE THERAPY; GENETIC VECTORS; IMMUNOENZYME TECHNIQUES; IMMUNOTHERAPY; LIPOSOMES; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MICE; MICE, INBRED BALB C; PERITONEAL NEOPLASMS; SENDAI VIRUS; TUMOR CELLS, CULTURED;

ANIMALIA; HUMAN PARAINFLUENZA VIRUS 1; MURINAE;

EID: 0035179573     PISSN: 09291903     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cgt.7700384     Document Type: Article

References (44)

1. Paracrine cytokine adjuvants in cancer gene therapy
2. Induction of antigen-specific anergy: An early event in the course of tumor progression
3. Self antigens expressed by solid tumors do not efficiently stimulate naíve or activated T cells: Implications for immunotherapy
4. Cancer vaccines
5. Chemokines and their role in tumor growth and metastasis
6. RANTES secretion by gene-modified tumor cells resulted in loss of tumorigenicity in vivo: Role of immune cell subpopulations
7. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells
8. A candidate for cancer gene therapy: MIP1-α gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice
9. Macrophage inflammatory protein 3α transgene attracts dendritic cells to established murine tumors and suppresses tumor growth
10. Combined chemokine and cytokine gene transfer enhances antitumor immunity
11. Resolution of the two components of macrophage inflammatory protein 1, and cloning and characterization of one of those components, macrophage inflammatory protein 1β
12. Identification, cloning, and characterization of an immune activation gene
13. Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP1-α, and MIP1-β, members of the chemokine superfamily of proinflammatory cytokines
14. Human macrophage inflammatory protein1-α (MIP1-α) and MIP1-β chemokines attract distinct populations of lymphocytes
15. Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP1-α, and MIP1-β on human monocytes
16. Functional diversity of helper T lymphocytes
17. Interleukin-12: A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cell type 1 and cytotoxic lymphocytes
18. Immunization and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with IL-2, IL-4, IL-6, IL-7, IL-10, TNF-α, GM-CSF and IFN-γ gene or admixed with conventional adjuvants
19. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine
20. Efficient introduction of contents of liposomes into cells using HVJ (Sendai virus)
21. The improved efficient method for introducing macromolecules into cell using HVJ (Sendai virus) liposomes with gangliosides
22. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus); reciprocal effect of cationic lipid for in vitro and in vivo gene transfer
23. Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen
24. Macrophage inflammatory protein1-α (MIP1-α) expression plasmid enhances DNA vaccine-induced immune response against HIV-1
25. CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines
26. Chemokines
27. + individuals: Correlation with a Th1-type cytokine response
28. Synthesis of the CC-chemokines MIP1-α, MIP1-β, and RANTES is associated with a type 1 immune response
29. Role of chemokines in the regulation of Th1/Th2 and autoimmune encephalomyelitis
30. Macrophage-derived dendritic cells have strong Th1-polarizing potential mediated by beta-chemokines rather than IL-12
31. Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines
32. + cells in response to MIP1-α and MIP1-β
33. CCR5 is characteristic of Th1 lymphocytes
34. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes
35. Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines
36. Expression and characterization of the chemokine receptors CCR2 and CCR5 in mice
37. Distinct patterns and kinetics of chemokine production regulate dendritic cell function
38. Chemokines: A new classification system and their role in immunity
39. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization
40. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes
41. Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome
42. Sustained transgene expression in vitro and in vivo using an Epstein-Barr virus replicon vector system combined with HVJ-liposomes
43. Gene therapy using HVJ liposomes; the best of both worlds?
44. Prolonged transgene expression in glomeruli using an Epstein-Barr Virus replicon vector system combined with AVE type HVJ liposomes